store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lamivudine (BCH-189) is a reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | In stock | $ 53.00 | |
100 mg | In stock | $ 79.00 | |
500 mg | In stock | $ 189.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Lamivudine (BCH-189) is a reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease. |
In vivo | Lamivudine exhibits selective inhibitory activity against deoxycytidine kinase, an unusual substrate for the non-natural L-isomer of dNTPs preferred by HBV polymerase. The anti-HBV activity of PCV is attributed to the broad substrate specificity of deoxycytidine kinase and an unusual substrate preference of HBV polymerase for the non-natural L-conformation of dNTPs. The anti-HBV efficacy of PCV appears to rely on multiple factors, including optimal phosphorylation (sufficient for antiviral activity but not cytotoxicity), the extended intracellular half-life of PCV-TP, and the ability of PCV-TP to inhibit the initiation of HBV RT as well as its RT and DNA polymerase activities. Combined use of Lamivudine and Cidofovir synergistically inhibits replication of duck hepatitis B virus and is more effective in reducing the persistent covalently closed circular (CCC) DNA form of DHBV than when used separately. In PBMCs, Lamivudine inhibits HIV-1 p24 antigen production with ED50s ranging from 0.07 μM to 0.2 μM. |
Synonyms | GR109714X, BCH-189 |
Molecular Weight | 229.26 |
Formula | C8H11N3O3S |
CAS No. | 134678-17-4 |
store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 43 mg/mL (187.6 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: 42 mg/mL (183.2 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lamivudine 134678-17-4 Microbiology/Virology Proteases/Proteasome HIV Protease Reverse Transcriptase Human immunodeficiency virus Hepatitis B virus susceptible HIV neurodegeneration GR109714X HBV BCH-189 HIV orally active BCH 189 CNS penetration,brain region BCH189 Inhibitor inhibit inhibitor